Utility of the Medtronic microvascular plug™ as a transcatheter implantable and explantable pulmonary artery flow restrictor in a swine model
Catheterization and Cardiovascular Interventions2019Vol. 93(7), pp. 1320–1328
Citations Over TimeTop 21% of 2019 papers
Abdul H. Khan, Deepthi Hoskoppal, T. K. Susheel Kumar, Lindsey Bird, Kimberly Allen, Hannah Lloyd, Christopher J. Knott‐Craig, B. Rush Waller, Shyam Sathanandam
Abstract
Transcatheter implantation and retrieval of the MVP as a PFR is feasible. PA growth is comparable to surgical PAB, which is likely to require reinterventions. The use of the MVP as a PFR in humans has to be trialed before recommending its routine use.
Related Papers
- Reduction of early elastic recoil by cutting balloon angioplasty as compared to conventional balloon angioplasty.(2002)
- → Percutaneous coronary laser balloon angioplasty: Initial results of a multicenter experience(1990)73 cited
- → Experience with laser—assisted balloon angioplasty and a rotary angioplasty instrument: Lessons learned(1991)8 cited
- → Cutting Balloon Angioplasty for Ostial Lesions of the Left Anterior Descending Artery(2000)2 cited
- Effect on C-reactive protein,interleukin-6 and intercellular adhesion molecule-1pre-and post-cutting balloon angioplasty(2003)